Cite
HARVARD Citation
Zhai, Y. et al. (2019). HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer. Radiotherapy and oncology. pp. 27-34. [Online].